Keywords: Parkinson's Disease, biomarkers, Diffusion Analysis & Visualization, Metabolism, Neuroinflammation, Spectroscopy, Glymphatic system
Motivation: Parkinson's disease (PD) has been linked to impaired glymphatic function, affecting brain waste clearance. However, the interplay between glymphatic function and specific metabolite changes in PD is not well understood.
Goal(s): This study aims to elucidate the relationship between glymphatic dysfunction and metabolic changes in PD and isolated REM sleep behavior disorder (iRBD), a potential precursor to PD.
Approach: We assessed the glymphatic function using the ALPS-index from DTI-ALPS and quantified metabolite ratios in PD and iRBD patients with 3T MRS.
Results: We found significant correlations between ALPS-index and key metabolites, suggesting an association between glymphatic dysfunction, neurotransmitter imbalances, and neuroinflammation in PD.
Impact: Our findings reveal that glymphatic dysfunction in PD may underlie metabolic disruptions, potentially serving as markers for neurodegenerative process. These insights could open new avenues for metabolic and glymphatic-based diagnostic and therapeutic strategies in neurodegenerative diseases.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords